BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
Sign in
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence
Back to Companies Directory

Recursion Pharmaceuticals

Recursion Pharmaceuticals logo

Website
https://www.recursion.com/
Founded
2013

Technologies

AI Companies (Drug Discovery) Gene Therapy Startups Pharmaceutical and Drug Discovery

Recursion Pharmaceuticals is a biotechnology company based in Salt Lake City. Recursion combines experimental biology, automation, and artificial intelligence in a massively parallel system to quickly and efficiently identify treatments for any disease which can be modeled at the cellular level. From its initial and continued focus on drug repurposing to treat rare diseases, Recursion has broadened its platform to probe rich data from high-throughput automated screens for a number of indications, including aging, inflammation, infectious disease, and immunology. Recursion is aggressively leveraging technology to build a robust and reliable map of human cellular biology, which will enable a radical shift in the pace and scale at which new treatments will benefit patients.


Articles Mentioning This Company

14 AI Drug Discovery Companies to Watch in 2026

14 AI Drug Discovery Companies to Watch in 2026

Oct. 15, 2026     Articles
AI drug discovery has moved from platform pitches to clinical tests. One recent sign: in October 2026, Iambic Therapeutics raised $150 million in a Nasdaq IPO, saying in its filing that its AI approach can "disrupt legacy drug discovery paradigms." Investors and pharma partners increasingly judge companies like Iambic on …
How Big Pharma Adopts AI To Boost Drug Discovery

How Big Pharma Adopts AI To Boost Drug Discovery

Oct. 9, 2025     Articles
(Last updated: October 2025) Since 1950, when Alan Turing introduced the concept of 'thinking machines', artificial intelligence has steadily advanced—from the rise of neural networks in the 1980s to the release of OpenAI’s GPT-3 in 2020, which paved the way for ChatGPT in 2022. Today, AI has become an integral …

17 Companies Pioneering AI Foundation Models in Pharma and Biotech

Sept. 30, 2025     Business Intelligence
Foundation models represent a relatively new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. Foundation models are a class of large-scale machine learning models, typically based on deep learning architectures such as transformers, that are trained on massive datasets encompassing diverse types of data. The …

R&D Platform

Conduct experimental biology at scale by testing thousands of compounds on hundreds of cellular disease models in parallel. Allows researchers to: Rapidly identify new indications for many known drugs and shelved assets.

News

  • 2025-10-29
    Recursion Completes Whole-Genome Microglia Map With Roche and Genentech
  • 2025-08-05
    Recursion Reports Q2 2025 with $7M Sanofi Milestone, Announces Clinical Updates
  • 2025-06-07
    MIT and Recursion Launch Boltz-2, Open-Source AI Foundation Model for Structure and Binding Affinity Prediction
  • 2024-12-09
    Recursion Reports Encouraging Interim Phase 1 Data a Selective CDK7 Inhibitor
  • 2024-08-08
    Breaking: In Arguably the Largest AI in Bio Deal, Recursion Acquires UK-based "End-to-End" AI Biotech Exscientia
  • 2024-05-14
    Recursion Unveils BioHive-2, Fastest Pharma-Owned Supercomputer
  • 2024-04-03
    New Landmark Report Unveils a Decade of AI Transformation in Drug Discovery
  • 2024-03-11
    Recursion Expands Its Presence with a New London Office and Bolsters Scientific Advisory Team
  • 2022-06-06
    Insilico Medicine Snaps Up $60M to Create Robotic Lab of the Future

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.